Solara Active Pharma Sciences Limited
Aditya Birla Sun Life Mutual Fund has dropped off Solara Active Pharma Sciences Limited's disclosed shareholder list after last reporting a 1.18 percent stake, indicating either a complete exit or a reduction below the 1 percent disclosure threshold.
A manufacturer of active pharmaceutical ingredients, Solara Active Pharma Sciences produces, formulates, and distributes APIs for pharmaceutical applications across domestic and international markets. The company engages in manufacturing, processing, and trading of these ingredients, with capabilities spanning production, import, export, and distribution. Its distinctive strength lies in vertical integration across the API supply chain and serving diverse pharmaceutical clients globally.
Joint venture between Aditya Birla Capital and Sun Life Financial of Canada. Among India's top five AMCs with over Rs 6.5 lakh crore in AUM across 100+ schemes. MD and CEO A. Balasubramanian is one of the most outspoken fund industry voices in India. CIO Mahesh Patil oversees the equity book with a consistent large and multicap tilt.